Literature DB >> 7781278

Molecular markers of hemostatic activation. Implications in the diagnosis of thrombosis, vascular, and cardiovascular disorders.

J Fareed1, R L Bick, D A Hoppensteadt, J M Walenga, H L Messmore, E W Bermes.   

Abstract

Until recently, the diagnosis of thromboembolic disorders remained difficult to establish before the occurrence of a pathologic event. Clearly, thrombosis is the result of a progressive alteration of the blood and vasculature. Various molecular markers of hemostatic alteration are found in increased or decreased amounts predisposing to thrombosis or in increased circulating amounts during the activation process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781278

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  2 in total

Review 1.  In Vitro models for thrombogenicity testing of blood-recirculating medical devices.

Authors:  Deepika N Sarode; Shuvo Roy
Journal:  Expert Rev Med Devices       Date:  2019-06-10       Impact factor: 3.166

2.  Increased levels of plasma thrombomodulin in patients with acute myocardial infarction who had thrombolytic therapy and achieved successful reperfusion.

Authors:  M Ileri; I Hisar; E Yetkin; F Koşar; S Cehreli; S Korkmaz; D Demirkan
Journal:  Clin Cardiol       Date:  2001-05       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.